The market may believe the company's recent revenue performa...
The market may believe the company's recent revenue performance is insufficient compared to the industry, given its low P/S ratio. Without top-line growth improvement, the ratio could fall further. Given recent revenue trends, significant share price movement seems unlikely soon.
Benign Growth For Realcan Pharmaceutical Group Co., Ltd. (SZSE:002589) Underpins Stock's 30% Plummet
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment